The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Following receipt of increasing peanut oral immunotherapy, or home-measured peanut butter, desensitization to peanut protein ...

Pursuing dangerous Medicaid block grant schemes and allowing flagrant violations of unequivocal state laws looks like ...

Medically reviewed by Alex Yampolsky, PharmD Hydroxyzine, whose brand names include Atarax and Vistaril, and Benadryl, the ...

The recently approved device simplifies operator manipulations by loading a balloon and filter onto the stent.

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...